|1.||Xia, Hong: 10 articles (08/2014 - 03/2004)|
|2.||Zhang, Kai: 7 articles (08/2014 - 03/2004)|
|3.||Ai, Fu-zhi: 6 articles (09/2010 - 03/2004)|
|4.||Yin, Qing-shui: 6 articles (09/2010 - 03/2004)|
|5.||Essand, Magnus: 5 articles (09/2012 - 08/2003)|
|6.||Wu, Zeng-hui: 5 articles (09/2010 - 03/2004)|
|7.||Mai, Xiao-hong: 4 articles (09/2010 - 03/2004)|
|8.||Pastan, Ira: 4 articles (06/2008 - 08/2003)|
|9.||Chang, Yun-bing: 4 articles (02/2008 - 03/2004)|
|10.||Liu, JingFa: 3 articles (08/2014 - 07/2005)|
04/15/2011 - "The authors' one-stage anterior procedure employing the TARP for the surgical treatment of irreducible anterior atlantoaxial dislocation and basilar invagination was effective in these two cases. "
02/01/2006 - "To study relevant anatomical features of the structures involved in transoral atlanto-axial reduction plate (TARP) internal fixation through transoral approach for treating irreducible atlanto-axial dislocation and providing anatomical basis for the clinical application of TARP. "
01/15/2006 - "To study relevant anatomic features of the structures involved in TARP internal fixation through transoral approach for treating irreducible atlantoaxial dislocation, so as to provide anatomic basis for the clinical application of TARP. "
08/01/2014 - "First initiated in 2005, transoral atlantoaxial reduction plate (TARP) works as an internal fixation for the treatment of basilar invagination with irreducible atlantoaxial dislocation. "
08/01/2014 - "Treatment of basilar invagination with atlantoaxial dislocation: atlantoaxial joint distraction and fixation with transoral atlantoaxial reduction plate (TARP) without odontoidectomy."
09/01/2010 - "We have previously shown that individuals infected with Chlamydia trachomatis can develop a robust antibody response to a Chlamydia type III secretion effector protein called Tarp and that immunization with Tarp induces protection against challenge infection in mice. "
07/12/2010 - "trachomatis-induced cell survival and suggest that Tarp functions as a multivalent phosphorylation-dependent signaling hub that is important during the early phase of chlamydial infection."
11/01/2009 - "trachomatis protein TARP, which is presynthesized in elementary bodies, plays an essential role in the initial stages of the infection. "
05/14/2009 - "Tarp was mainly associated with the infectious form of chlamydial organisms and became undetectable between 13 and 24 h during the infection cycle in cell culture. "
12/01/2008 - "These data reveal a highly promiscuous substrate property of Tarp and set the stage for further functional characterization of Tarp phosphorylation during host cell infection."
|3.||Prostatic Neoplasms (Prostate Cancer)
06/01/2010 - "We analysed the protein expression of TARP in a large well characterised prostate cancer cohort to assess its diagnostic and prognostic value. "
09/01/2005 - "Among these were several known prostate cancer relevant genes, such as AMACR, TARP, LIM, GPR160 (all up-regulated), CAV1, NTN1, MT1X; CLU, TRIM29, SPARCL1 and HSPB8 (all down-regulated)."
06/04/2004 - "Immunohistochemistry using a human prostate cancer sample showed that TP1 reacted in a dot-like cytoplasmic pattern consistent with the presence of TARP in mitochondria. "
08/01/2003 - "We further demonstrate that the promoter specifically initiates reporter gene expression in TARP-positive prostate cancer cell lines. "
11/15/2001 - "These results suggest that TARP has a role in regulating growth and gene expression in prostate cancer cells."
05/01/2005 - "The aim of the present study was to use immunohistochemistry and semi-quantitative histomorphometric analysis to compare the distribution and relative abundance of AQP1 on NCI TARP human multiple tumor tissue microarrays (TMAs) with normal tissues represented on the CHTN TMAs. "
12/01/2012 - "Our findings demonstrated that the feline TARP ortholog is transcribed in the prostate gland and mammary tumors but not normal mammary tissues as is the case with human TARP."
06/01/2010 - "Additionally, TARP has been proposed as a potential therapeutic target for cancer therapy. "
05/26/2005 - "Detection and scoring of TACC1 and TACC3 expression was performed by immunohistochemical analysis of the T-BO-1 tissue/tumor microarray slide from the Cooperative Human Tissue Network, Tissue Array Research Program (TARP) of the National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. "
05/15/2005 - "Our results show that TARP constitutes a TAA that can be recognized by tumor-reactive HTL. "
10/01/2009 - "The Therapy Assessed by Rising PSA (TARP) study investigates dutasteride in combination with bicalutamide to prevent or delay disease progression in patients with castrate-refractory prostate cancer (CRPC) after initial androgen deprivation therapy. "
05/01/2009 - "Ongoing trials that will further clarify the role of 5-ARIs in preventing and treating PCa include the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) with dutasteride in PCa risk reduction; the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial on the effect of dutasteride on disease progression in low-grade localized PCa; and the Therapeutic Assessment of Rising PSAs [prostate-specific antigens] (TARP) trial on dutasteride in asymptomatic recurrent cancer. "
|5.||Prostate-Specific Antigen (Semenogelase)
|7.||gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)
|8.||T-Cell Antigen Receptors (T-Cell Receptor)
|9.||Staphylococcal Protein A (A, Protein)
|10.||T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)
|3.||Prostatectomy (Retropubic Prostatectomy)